Connor, Clark & Lunn Investment Management Ltd. Zai Lab LTD Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 604,153 shares of ZLAB stock, worth $16.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

604,153

Previous 478,621 26.23%

Holding current value

$16.1 Million

Previous $8.29 Million 75.84%

% of portfolio

0.08%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$16.25 - $24.14 $2.04 Million - $3.03 Million	125,532 Added 26.23%	604,153 $14.6 Million
Q2 2024 Aug 09, 2024	BUY	$13.72 - $21.55 $1.53 Million - $2.41 Million	111,701 Added 30.44%	478,621 $8.29 Million
Q1 2024 May 09, 2024	BUY	$15.95 - $26.8 $2.63 Million - $4.43 Million	165,147 Added 81.85%	366,920 $5.88 Million
Q4 2023 Feb 09, 2024	BUY	$22.97 - $30.58 $436,131 - $580,622	18,987 Added 10.39%	201,773 $5.51 Million
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $995,090 - $1.38 Million	-43,798 Reduced 19.33%	182,786 $4.44 Million
Q2 2023 Aug 10, 2023	BUY	$25.3 - $39.67 $2.62 Million - $4.11 Million	103,701 Added 84.39%	226,584 $6.28 Million
Q1 2023 May 09, 2023	SELL	$30.21 - $48.1 $2.13 Million - $3.39 Million	-70,519 Reduced 36.46%	122,883 $4.09 Million
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $1.56 Million - $2.7 Million	69,863 Added 56.55%	193,402 $5.94 Million
Q3 2022 Nov 10, 2022	BUY	$34.2 - $51.69 $1.19 Million - $1.8 Million	34,799 Added 39.21%	123,539 $4.23 Million
Q2 2022 Aug 05, 2022	BUY	$23.14 - $49.68 $698,712 - $1.5 Million	30,195 Added 51.58%	88,740 $3.08 Million
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $1.34 Million - $3.1 Million	-48,075 Reduced 45.09%	58,545 $2.58 Million
Q4 2021 Feb 10, 2022	BUY	$54.9 - $105.21 $194,236 - $372,232	3,538 Added 3.43%	106,620 $6.7 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $6.65 Million - $11.3 Million	63,324 Added 159.27%	103,082 $10.9 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $2.78 Million - $4 Million	22,234 Added 126.88%	39,758 $7.04 Million
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $2.21 Million - $3.36 Million	17,524 New	17,524 $2.34 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Zai Lab LTD Transaction History